Fresh2 Group Limited (NASDAQ: FRES)
$2.85
+0.0900 ( +3.26% ) 10.1K
Fresh2 Group Ltd is a biotechnology company. It focuses on early cancer screening and detection. The company markets and sells a multi-cancer screening and detection test that uses its innovative patented CDA technology and its proprietary CDA device. In addition to early cancer screening and detection, its CDA technology has demonstrated the potential to assist physicians in cancer diagnosis, prognosis, and recurrence.
Market Data
Open
$2.85
Previous close
$2.76
Volume
10.1K
Market cap
$6.61M
Day range
$2.56 - $2.92
52 week range
$2.50 - $41.80
SEC Fillings
Form Type | Description | Pages | Date |
---|---|---|---|
8-k | 8K-related | 14 | Jun 26, 2024 |
8-k | 8K-related | 14 | May 23, 2024 |
8-k | 8K-related | 14 | Apr 22, 2024 |
8-k | 8K-related | 15 | Apr 02, 2024 |
nt | Quarterly Reports | 1 | Apr 02, 2024 |
8-k | 8K-related | 14 | Mar 27, 2024 |
20-f/a | Annual reports | 130 | Mar 25, 2024 |
8-k | 8K-related | 20 | Mar 25, 2024 |
8-k | 8K-related | 15 | Mar 25, 2024 |
8-k | 8K-related | 17 | Feb 16, 2024 |